ArticleBMJ open2020
Health and productivity burden of coronary heart disease in the working Indonesian population using life-table modelling.
Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.
- Daytime napping and coronary heart disease risk in adults: a systematic review and dose-response meta-analysis.Sleep & breathing = Schlaf & Atmung · 2023Pooled it
- Plant Sterol-Enriched Palm Oil Intervention to Improve Lipid Profile and Inflammation Status in Hyperlipidemic Individuals.Nutrients · 2024Trial
- Pharmacists' perspectives on medication therapy management training needs for chronic disease care in Indonesian primary healthcare centers: a qualitative study across 32 provinces.BMC medical education · 2026Article
- Scoping Review of Productivity-Adjusted Life Years (PALYs): Methods, Applications and Policy Implications.PharmacoEconomics · 2025Article
- Monetary Valuation of Congenital Heart Disease in Indonesia: Economic Modeling Study.JMIR pediatrics and parenting · 2025Article
- Sickness absences and losses in productivity-adjusted life years before, during and after the most common orthopedic surgical procedures among employed individuals in Finland.BMC health services research · 2025Observational
- Productivity Losses Due to Long-Term Back Problems in Working-Age Australians.JAMA network open · 2025Article
- Estimation of economic burden of high salt intake in cardiovascular disease attributed to hypertension in Iran.Cost effectiveness and resource allocation : C/E · 2025Article
- Article
- Coronary heart disease risk factors among academic workers based on the Jakarta Cardiovascular Score: A cross-sectional study.Narra J · 2023Article
- Productivity burden of hypertension in Japan.Hypertension research : official journal of the Japanese Society of Hypertension · 2021Article
- Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden.PharmacoEconomics · 2021Article
- Cross-Sectional Study of Plant Sterols Intake as a Basis for Designing Appropriate Plant Sterol-Enriched Food in Indonesia.Nutrients · 2021Article
- Illness cognition and depression among patients with coronary heart disease.Belitung nursing journal · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe impact of coronary heart disease (CHD) and its effect on work productivity at a population level remains unknown in Indonesia. This study estimates the health and productivity lost to CHD in terms of years of life, quality-adjusted life years (QALYs) and productivity-adjusted life years (PALYs). SETTING AND
participantsA life-table model was constructed to simulate the experiences of Indonesians currently aged 15-54 years (working age) with CHD, followed-up to 55 years (retirement age). The life-table analysis was then repeated assuming that the cohort did not have CHD. Differences in the results reflected the impact of CHD. Demographical, prevalence and mortality data were based on the 2017 Global Burden of Disease study and 2018 Indonesian National Health Survey. Costs, productivity indices and utilities were derived from published sources. The cost of each PALY was assumed to be equivalent to gross domestic product per equivalent full-time worker (US$11 765). Future costs and outcomes were discounted by 3% annually. PRIMARY AND SECONDARY OUTCOME MEASURES: Differences in total deaths, years of life and PALYs represented the impact of CHD.
resultsAt present, 1 954 543 (1.45%) Indonesians of working-age have CHD. By retirement age, it was estimated that CHD resulted in 32 492 (36.6%) excess deaths, 128 132 (0.5%) years of life lost, 2 331 495 (10.5%) QALYs lost and 1 589 490 (6.9%) PALYs lost. The economic impact of lost productivity amounted to US$33.3 billion, and healthcare costs to US$139 billion.
conclusionThe health and economic burden of CHD in Indonesia looms large. This highlights the importance of its prevention and control, strategies for which, if effective, will deliver financial return.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.